Sargent Bickham Lagudis’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Sargent Bickham Lagudis’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-225	Closed	–	–	1014
2020 Q4	$0	Hold	225	–	–	﹤0.01%	933
2020 Q3	$1K	Hold	225	–	–	﹤0.01%	783
2020 Q2	$1K	Hold	225	–	–	﹤0.01%	761
2020 Q1	$1K	Sell	225 -362	-62%	-$1.19K	﹤0.01%	764
2019 Q4	$2K	Buy	+587	New	+$1.53K	﹤0.01%	790

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return

TNB

Thomasville National Bank Thomasville, Georgia $1.82B AUM

WAM

Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return

IAIM

International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Sargent Bickham Lagudis's BMY.RT Position: Q1 2021 in Review

Sargent Bickham Lagudis sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 225 shares.

Sargent Bickham Lagudis first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $2K in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

Sargent Bickham Lagudis reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
Sargent Bickham Lagudis sold 225 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
Sargent Bickham Lagudis first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
Sargent Bickham Lagudis's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $2K in Q4 2019.
12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Sargent Bickham Lagudis's 13F filing for Q1 2021, filed 24 May 2021.